BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19706857)

  • 1. Prevalence of breast carcinoma in situ in the United States.
    Sprague BL; Trentham-Dietz A
    JAMA; 2009 Aug; 302(8):846-8. PubMed ID: 19706857
    [No Abstract]   [Full Text] [Related]  

  • 2. William Hunter Harridge Lecture: Contemporary management of pre-invasive and early breast cancer.
    Bland KI
    Am J Surg; 2011 Mar; 201(3):279-89. PubMed ID: 21367364
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast carcinoma in situ.
    McDermott FT
    Aust N Z J Surg; 1992 Nov; 62(11):841-8. PubMed ID: 20169700
    [No Abstract]   [Full Text] [Related]  

  • 4. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
    Li CI; Daling JR; Malone KE
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1008-11. PubMed ID: 15824180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer statistics: Breast cancer in situ.
    Ward EM; DeSantis CE; Lin CC; Kramer JL; Jemal A; Kohler B; Brawley OW; Gansler T
    CA Cancer J Clin; 2015; 65(6):481-95. PubMed ID: 26431342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive lobular carcinoma incidence increasing.
    CA Cancer J Clin; 2003; 53(3):137. PubMed ID: 12817609
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).
    Nakhlis F; Gilmore L; Gelman R; Bedrosian I; Ludwig K; Hwang ES; Willey S; Hudis C; Iglehart JD; Lawler E; Ryabin NY; Golshan M; Schnitt SJ; King TA
    Ann Surg Oncol; 2016 Mar; 23(3):722-8. PubMed ID: 26542585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast--a review.
    Hussain M; Cunnick GH
    Eur J Surg Oncol; 2011 Apr; 37(4):279-89. PubMed ID: 21306860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do not jump too quickly to conclusions.
    Kopans DB
    Breast Cancer Res; 2012 Jul; 14(4):108. PubMed ID: 22824314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobular neoplasia. Long term risk of breast cancer and relation to other factors.
    Bodian CA; Perzin KH; Lattes R
    Cancer; 1996 Sep; 78(5):1024-34. PubMed ID: 8780540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. StatBite: Relative survival and incidence rates: ductal carcinoma in situ.
    J Natl Cancer Inst; 2010 Jan; 102(1):8. PubMed ID: 20023203
    [No Abstract]   [Full Text] [Related]  

  • 12. What is atypical lobular hyperplasia and what does it mean for the patient?
    Page DL; Simpson JF
    J Clin Oncol; 2005 Aug; 23(24):5432-3. PubMed ID: 16110003
    [No Abstract]   [Full Text] [Related]  

  • 13. The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry.
    Claus EB; Stowe M; Carter D; Holford T
    Breast; 2003 Dec; 12(6):451-6. PubMed ID: 14659121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
    Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Cushing-Haugen KL; Daling JR
    JAMA; 2003 Jun; 289(24):3254-63. PubMed ID: 12824206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lobular carcinoma in situ: current concepts and controversies.
    Schnitt SJ; Morrow M
    Semin Diagn Pathol; 1999 Aug; 16(3):209-23. PubMed ID: 10490198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in incidence rates of invasive lobular and ductal breast carcinoma.
    Li CI; Anderson BO; Daling JR; Moe RE
    JAMA; 2003 Mar; 289(11):1421-4. PubMed ID: 12636465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer: a review of the literature.
    Richie RC; Swanson JO
    J Insur Med; 2003; 35(2):85-101. PubMed ID: 14733031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women's health centers.
    Desouki MM; Li Z; Hameed O; Fadare O; Zhao C
    Hum Pathol; 2013 Sep; 44(9):1877-81. PubMed ID: 23656973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States).
    Newcomer LM; Newcomb PA; Potter JD; Yasui Y; Trentham-Dietz A; Storer BE; Longnecker MP; Baron JA; Daling JR
    Cancer Causes Control; 2003 Apr; 14(3):225-33. PubMed ID: 12814201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.